Response Biomedical Corp. (fka RPBIF)

[dimonfind]

The Point of Care Diagnostic Testing World Markets Report Describes Products Segments That are Poised for a Major New Phase of Growth Fuelled by the Availability of New Technology
Monday October 4, 10:04 am ET


DUBLIN, Ireland, Oct. 4 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com ) has announced the addition of Point of Care Diagnostic Testing -- World Markets to their offering.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040820/RESEARCH )
This report examines of the worldwide Point of Care Diagnostic testing sector in a quantitative, business and market oriented treatment. Focusing on new technologies, new markets for near patient diagnostic products and new attitudes of patients and healthcare providers, this report is a sourcebook of data and analysis about the fastest growing sector of the $21 billion worldwide diagnostic industry whose products are transforming the practice of medicine.

The Point of Care Diagnostic Testing World Markets report describes products segments that are poised for a major new phase of growth fuelled by the availability of new technology platforms an the demand for more efficient medical service.

Near patient tests, including those for blood glucose, pregnancy, ovulation, coagulation, cholesterol, drugs, infectious disease and various urine components, are in high demand as physicians and patients realize their potential for promoting improved health care.

The POC market for diagnostic tests in the United States increased at a phenomenal compounded annual growth rate, and many parts of the world market grew at comparable rates, with Germany as the leader in Europe and high rates of growth in rest of the world including Asia and Japan. This report examines market sizes and growth rates for important country markets in Europe and Asia, including China.

This report examines the three basic factors have driven the market for Point of Care diagnostic testing products, and looks at the POC market's two general segments: the hospital market and the physician's office. The POC market encompasses a large variety of IVD products ranging from moderate sized instrumented diagnostic systems serving larger institutional uses to single- use, disposable tests for individual home use.

This report discusses Point of Care Diagnostic product industry trends that are believed to influence POC testing, including demographic changes, reimbursement policies, regulations, and the availability of clinically valuable tests that will increase growth in this diagnostic category. Detailed discussions of regulatory requirements for point of care diagnostic products for the U.S., Japan, and the EU are presented.

The report also includes discussions of Competitive Outlook, and Market Strategies. It also covers specific at point of care testing areas such as Glucose Monitoring, Pregnancy Testing, Hepatitis Testing, Drugs of Abuse Screening Testing, Infectious Disease Testing, HIV, Coagulation Testing and Fertility Testing.

There is also an important discussion of the emerging technologies for point of care diagnostics and the implications of molecular biology and genomics for new rapid diagnostic tests. Exiting new technology areas such as Protein Sequencing, DNA Sequencing and The Human Genome Project are placed into the context of their impact on rapid diagnosis.

Market Trends and Forecasts in point of care diagnostics such as the move to electro-detection for rapid glucose analyzers, Mergers and Acquisitions of Diagnostic Companies, emerging rapid tests for infectious disease, Rt-pcr, new cardiac monitors and more are reported in detail, and the strategies of the key industry players is discussed.

Finally, this report summarizes the business developments of over 100 companies from all parts of the world that market and manufacture point of care diagnostic products. Key merger and acquisition data are included.

The Point of Care Diagnostic Testing World Markets report is constantly updated, so that all important developments throughout the current year are included in the report.

This report provides not only the factual details of the rapid diagnostic testing segment, but answers, "why it is significant" and "what does it mean for your company". A leading expert in diagnostic testing and marketing wrote the report.

1. Overview
2. Introduction
3. Point of Care Testing: Market Segment Analysis: Size, Growth, Share
4. Point of Care Testing: Reagents and Equipment
5. Point of Care Testing: Hospital Issues
6. Business Trends In The Industry
8. Corporate Profiles

-- Abaxis
-- Lifescan Inc.
-- Orasure
-- Bayer
-- Nova
-- Savyon Diagnostics
-- Spectral Diagnostics Inc.
-- Biosite Diagnostics
-- Abbott Laboratories
-- Instrumentation Laboratories
-- MedMira Laboratories
-- Diametrics Medical Inc.
-- Radiometer
-- Chiron Diagnostics
-- Gen Bio
-- Ely Labs
-- Orgenics
-- BioMerieux Vitek, Inc.
-- Cortec Ltd.
-- Ani Biotech
-- Sybron International Corporation
-- Optical Sensors Inc.
-- Worldwide Medical
-- International Medical Inovations
-- Cardiovascular Diagnostics Inc.
-- Abaxis Inc.
-- Carter-Wallace Inc.
-- Chemtrak Inc.
-- Cholestech Corp.
-- Hemocue Inc.
-- Binax
-- Selfcare Inc./Inverness Medical
-- Johnson & Johnson
-- Accumetrics, Inc.
-- First Medical, Inc.
================================================================
-- Response Biomedical Corp.
================================================================
-- Compucyte Corporation
-- Caliper Technologies
-- Diagnostic products Corporation
-- Murex Corporation
-- Princeton BioMeditech Corp.
-- American Biogenic Sciences
-- New Horizons Diagnostics
-- Beacon Diagnostics
-- Saliva Diagnostics
-- Calypte Biomedical
-- Meridian Diagnostics
-- Quidel
-- Biomerica
-- Diagnology
-- Biostar
-- Actimed Diagnostics
-- Empyrean Diagnostics
-- S.T.C. Technolgies
-- Trinity Diagnostics
-- Genzyme Diagnostics
-- ImmunoScience
-- Cygnus Therapeutic Systems
-- Seradyn Clinical Diagnostics/Apogent
-- Adeza Biomedical Corporation
-- Array Medical
-- TransMedica
-- Bioscan, Inc.
-- American Bio Medica Corp.
-- GDS Diagnostics
-- Home Access Health Corp
-- Pharmatech Corporation
-- Thoratec/International Technidyne Corp
-- Int'l Immunodiagnostics
-- Avocet Medical
-- SpectRx, Inc
-- Helena Laboratories
-- Technical Chemicals & Products
-- Roche Diagnostics
-- Simplex Medical Systems
-- Biex Inc.
-- Point of Care Technologies
-- LXN Corp (Inverness Medical Technology)
-- American Biogenetic Sciences, Inc.
-- Lifestream Diagnostics
-- PanBio Corp
-- Phillips Medical Systems
-- Jiangnan Biotech. Co., Ltd.
-- Minimed, Inc
-- Meretek Corporation
-- AVOX Systems
-- Dade Behring
-- Chongquing Sungene Pharmaceutical Co.
-- Medical Services International
-- Therasense, Inc.
-- Pharmanetics
-- Kehua Biotech
-- LifePoint, Inc.
-- Avitar
-- Cozart Biosciences
-- Enterix, Inc.
-- Kyowa Medex Co., Ltd.
-- Iatron
-- Denka Seiken Co., Ltd.
-- Accurex Biomedical, Pvt., Ltd.

9. Market Trends & Forecasts
10. Corporate Directory

For more information visit http://www.researchandmarkets.com/reports/c5753

Laura Wood
Senior Manager
Research and Markets
[e-mail]
Fax: [phone]